Product
Company
- People
- FAQ
Investor Centre
News
Contact Us

Home » News » OnMarket Video: TruScreen Group Ltd

OnMarket Video: TruScreen Group Ltd

TruScreen CEO, Victoria Potarina, discusses the upcoming ASX dual listing and the accompanying IPO.

Discover TruScreen

Quick Links

Product
Company
Investor Centre
News
FAQ
Contact
Privacy Policy

Contact

+61 0 2 8999 3820

info@truscreen.com

TruScreen
PO Box Q128
QUEEN VICTORIA BUILDING
Sydney, NSW, 1320
Australia

TruScreen Group Limited (NZX/ASX: TRU) is a New Zealand and Australian listed medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. Unlike many cervical screening devices, that have only triage/adjunct functionality, the TruScreen device is registered as a stand alone primary screening tool.

© 2024 Truscreen, Inc. All rights reserved.